FRIDAY, APRIL 22, 2011
6 Legally-Sanctioned ATC in NJ Have Been Announced
The six legally-sanctioned growers and sellers for New Jersey's medical marijuana have just been announced by the state health department.

They are:

Breakwater Alternative Treatment Center, Corp., Ocean, Central Region; Board of Trustees/Officers: Richard Lefkowitz, CEO; H. Alexander Zaleski, COO. The ATC would be located in Manalapan, Monmouth County.

Compassionate Care Centers of America Foundation Inc. (CCCAF), Jersey City, Central Region; Board of Directors: David Weisser, Michael Weisser and Anastasia Burlyuk. The ATC would be located in New Brunswick, Middlesex County.

Compassionate Care Foundation Inc., West Trenton, Southern Region; Board of Trustees: William J. Thomas, David Knowlton, James C. Herrmann, Ann Marie Hill, Jeffrey Warren, JoAnn Lange, Mark Dumoff. The ATC would be located in Bellmawr, Camden County

Compassionate Sciences, Inc. ATC, Sea Cliff, NY, Southern Region; Board of Trustees, CEO Richard Taney, Dr. Steven Paterno, CFO Jack Burkolder; Webster Todd. The location of the ATC is undetermined, but will be located in either Burlington or Camden County

Foundation Harmony, Cliffside Park, Northern Region; Board of Directors: Maria Karavas, Ida Umanskaya, Margarita Ivanova and Dmitri Bajanov. The ATC would be in Secaucus, Hudson County

Greenleaf Compassion Center, Montclair, Northern Region; Board of Trustees: Joseph Stevens, president, CEO; Jordan A. Matthews, Robert J. Guarino. The ATC would be in Montclair, Essex County

The state health department released the winning applicants today, despite the Legislature's intent to repeal the medical marijuana program rules draft by the Christie administration. The law's Senate sponsors said they would rather overturn the proposed rules and start over, delaying the start of the program, than allow such restrictive regulations to move forward.

FRIDAY, APRIL 22, 2011
THC Cures Cancer, Harvard Study
http://youtu.be/dSXhwP5QjUQ
TUESDAY, AUGUST 28, 2012
Teen Marijuana Use

NEW YORK — Teens who routinely smoke marijuana risk a long-term drop in their IQ, a new study suggests.

The researchers didn’t find the same IQ dip for people who became frequent users of pot after 18. Although experts said the new findings are not definitive, they do fit in with earlier signs that the drug is especially harmful to the developing brain.

"Parents should understand that their adolescents are particularly vulnerable,"’ said lead researcher Madeline Meier of Duke University.

Study participants from New Zealand were tested for IQ at age 13, likely before any significant marijuana use, and again at age 38. The mental decline between those two ages was seen only in those who started regularly smoking pot before age 18.

Richie Poulton, a study co-author and professor at the University of Otago in New Zealand, said the message of the research is to stay away from marijuana until adulthood if possible. "For some it’s a legal issue," he said, "but for me it’s a health issue."

Pot is the most popular illegal drug in the world, with somewhere between 119 million and 224 million users between the ages of 15 and 64 as of 2010, the United Nations reported. Within the United States, 23 percent of high school students said they’d recently smoked marijuana, making it more popular than cigarettes, the federal government reported in June.

Young people "don’t think it’s risky," said Staci Gruber, a researcher at the Harvard-affiliated MacLean Hospital in Belmont, Mass.

Gruber, who didn’t participate in the new work, said the idea that marijuana harms the adolescent brain is "something we believe is very likely" and the new finding of IQ declines warrants further investigation.

Experts said the new research is an advance because its methods avoid criticisms of some earlier work, which generally did not measure mental performance before marijuana use began.

marijuana-smoker.JPGA file photo taken in April 2012 shows a demonstrator smoking a marijuana joint in the southeastern Dutch city of Maastricht to protest against the introduction of a new law forcing cannabis cafe owners in the southern Netherlands to sell their product to Dutch residents only.

"I think this is the cleanest study I've ever read" that looks for long-term harm from marijuana use, said Dr. Nora Volkow, director of the National Institute on Drug Abuse, which helped fund the research.

Ken Winters, a psychiatry professor at the University of Minnesota and senior scientist at the Treatment Research Institute in Philadelphia, said the new findings aren't definitive, but they underscore the importance of studying how marijuana may harm young people. He had no role in the work.

Meier and colleagues reported their work online Monday in the Proceedings of the National Academy of Sciences. It was funded with governmental grants from the United States and Britain, and a foundation in Zurich.

The study drew on survey data from more than 1,000 people in New Zealand, everybody born in the town of Dunedin during a year-long span ending in 1973. In addition to IQ tests, they were interviewed five times between ages 18 and 38, including questions related to their marijuana use.

At age 18, 52 participants indicated they had become dependent on marijuana, meaning that they continued to use it despite its causing significant health, social or legal problems. Ninety-two others reported dependence starting at a later age.

Researchers compared their IQ scores at age 13 to the score at age 38 and found a drop only in those who had become dependent by 18.

Those deemed dependent in three or more surveys had a drop averaging 8 points. For a person of average intelligence, an 8-point drop would mean ranking higher than only 29 percent of the population rather than 50 percent, the researchers said.

Among participants who'd been dependent at 18 and in at least one later survey, quitting didn't remove the problem. IQ declines showed up even if they'd largely or entirely quit using pot at age 38, analysis showed.

The researchers got similar overall results for IQ decline when they compared participants who reported having used marijuana at least once a week on average for the past year. The researchers had no data on how much was used on each occasion or how potent it was.

Duncan Clark, a researcher at the University of Pittsburgh, said he's not convinced that mental decline is only in those who become dependent by age 18. He said the main lesson he sees in the overall study results is that to preserve one's IQ, it's best to avoid marijuana entirely, no matter what your age.

The researchers also surveyed people who knew the study participants well at age 38. They found that the more often participants were rated as marijuana-dependent in the surveys over their lifetimes, the more memory and attention problems were noticed by their acquaintances over the previous year.

WEDNESDAY, DECEMBER 28, 2011
New Proposed Rules for the MMP
THURSDAY, AUGUST 02, 2012
Less then 1% THC
Home > MMJ Vendor & Supplier News > 10 Israeli Medical M...
July 3, 2012

10 Israeli Medical Marijuana Patients Testing THC-Free Cannabis: Reduces Pain Without That Annoying Side Effect

Tags: 
Medical marijuana regulations, cannabis laws and general MMJ news
 By Anne Holland

Tikun Olam, a licensed medical marijuana growing facility in Israel, announced today that for the last six months it’s been running limited human patient trials of Avidekel, a new strain of cannabis which has 15.8% CBD but less than 1% THC. Plenty of mice and ten human patients have tried the new strain so far. We can’t speak for the mice, but human patients are saying they appreciate having the benefits of CBD without the side affects of THC.

CBD is Cannabidiol, a substance with anti-inflammatory benefits that may help rheumatoid arthritiscolitis, liver inflammation, heart disease and diabetes. So, it doesn’t do everything that researchers claim THC-bearing cannabis can, but even these partial benefits are well worth investigating, especially for patients who don’t appreciate getting high.

WEDNESDAY, NOVEMBER 17, 2010
AMA Ends 72-Year Policy, Says Marijuana has Medical Benefits
Opinion by ASA 
(November 10, 2009) in Society / Drug Law

HOUSTON --- The American Medical Association (AMA) voted today to reverse its long-held position that marijuana be retained as a Schedule I substance with no medical value. The AMA adopted a report drafted by the AMA Council on Science and Public Health (CSAPH) entitled, "Use of Cannabis for Medicinal Purposes," which affirmed the therapeutic benefitsof marijuana and called for further research. The CSAPH report concluded that, "short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis." Furthermore, the report urges that "the Schedule I status of marijuana be reviewed with the goal of facilitating clinical research and development of cannabinoid-based medicines, and alternate delivery methods."

The change of position by the largest physician-based group in the country was precipitated in part by a resolution adopted in June of 2008 by the Medical Student Section (MSS) of the AMA in support of the reclassification of marijuana's status as a Schedule I substance. In the past year, the AMA has considered three resolutions dealing with medical marijuana, which also helped to influence the report and its recommendations. The AMA vote on the report took place in Houston, Texas during the organization's annual Interim Meeting of the House of Delegates. The last AMA position, adopted 8 years ago, called for maintaining marijuana as a Schedule I substance, with no medical value.

"It's been 72 years since the AMA has officially recognized that marijuana has both already-demonstrated and future-promising medical utility," said Sunil Aggarwal, Ph.D., the medical student who spearheaded both the passage of the June 2008 resolution by the MSS and one of the CSAPH report's designated expert reviewers. "The AMA has written an extensive, well-documented, evidence-based report that they are seeking to publish in a peer-reviewed journal that will help to educate the medical community about the scientific basis of botanical cannabis-based medicines." Aggarwal is also on the Medical & Scientific Advisory Board of Americansfor Safe Access (ASA), the largest medical marijuana advocacy organization in the U.S.

The AMA's about face on medical marijuana follows an announcement by the Obama Administration in October discouraging U.S. Attorneys from taking enforcement actions in medical marijuana states. In February 2008, a resolution was adopted by the American College of Physicians (ACP), the country's second largest physician group and the largest organization of doctors of internal medicine. The ACP resolution called for an "evidence-based review of marijuana's status as a Schedule I controlled substance to determine whether it should be reclassified to a different schedule. "The two largest physician groups in the U.S. have established medical marijuana as a health care issue that must be addressed," said ASA Government Affairs Director Caren Woodson. "Both organizations have underscored the need for change by placing patients above politics."

Though the CSAPH report has not been officially released to the public, AMA documentation indicates that it: "(1) provides a brief historical perspective on the use of cannabis as medicine; (2) examines the current federal and state-based legal envelope relevant to the medical use of cannabis; (3) provides a brief overview of our current understanding of the pharmacology and physiology of the endocannabinoid system; (4) reviews clinical trials on the relative safety and efficacy of smoked cannabis and botanical-based products; and (5) places this information in perspective with respect to the current drug regulatory framework."

Further information:

Executive Summary of AMA Report
Recommendations of AMA Report
American College of Physicians resolution

THURSDAY, JULY 21, 2011
Contact for Media
Princeton Public Affairs Group, Inc.
Alfred J. Gaburo-Spokesman
Contact Phone Number:
(609) 396-8838
THURSDAY, JULY 21, 2011
N.J. medical marijuana program will get rolling after 3-month delay
christie.jpgGov. Christie says providing compassionate pain relief to citizens outweighs the risk the state is taking in implementing its medical marijuana program.

TRENTON � Gov. Chris Christie Tuesday said he will order state officials to quickly implement New Jersey�s medical marijuana program, a move growers say could allow the drug to be sold to chronically ill patients by the end of the year.

Christie said the state health department should �move forward as expeditiously as possible,� lifting a three-month hold he imposed while waiting for federal law enforcement officials to tell him whether state workers or private growers would be vulnerable to arrest.

�I believe that the need to provide compassionate pain relief to these citizens of our state outweighs the risk that we are taking in moving forward with the program as it is set up,� Christie said in a Statehouse news conference.

The green light from the administration means the six nonprofit organizations authorized to sell the marijuana will be told to get to work opening a store and begin growing as soon as possible.

At some point � although health officials have not said when � patients recommended by their doctor to enroll in the program will be told to apply for an identification card and to place their name on a state patient registry.

Christie said he had been waiting since April for the Obama administration to clarify a concern raised by other governors that state employees affiliated with the program could run the risk of arrest by federal law enforcement officials. Possessing and selling marijuana remains a federal crime, even though 16 states have enacted medical marijuana laws.

A memo by U.S. Deputy Attorney General James Cole on June 30 did not specifically answer the questions about immunity for state or private employees, said Christie, a former U.S. attorney, but �gave us some hints� as to whether federal authorities would scrutinize legitimate medical marijuana employees. He said he�s betting they won�t.

Video: Gov. Christie gives go-ahead for N.J. medical marijuana program Video: Gov. Christie gives go-ahead for N.J. medical marijuana program Gov. Chris Christie today said the state will move forward with a "limited, medically-based" medical marijuana program. Though it's not a law he would have signed, he said his priority is getting care to those who need it. (Video by Megan DeMarco / The Star-Ledger) Watch video

Cole�s memo expressed concern about �an increase in scope of commercial cultivation, sale, distribution and use of marijuana for purported medical purposes� in some unidentified states. Christie has insisted that New Jersey�s program be tightly regulated to make sure only chronically ill people can have access to the drug.

The governor�s announcement came as a relief to dispensary owners as well as patients, who were frustrated because they had been told he drug would be available this summer.

TUESDAY, APRIL 17, 2012
MMJ Program List of Participating Physicians
TUESDAY, NOVEMBER 16, 2010
MEDICAL MARIJUANA: New Jersey Will Re-Propose Rules

The New Jersey Department of Health & Senior Services (DHSS) and the Medicinal Marijuana Program will re-propose the rules to implement the New Jersey Compassionate Use of Medical Marijuana Act. N.J.S.A 24:61-1. The newly proposed rules can be found in the February 22, 2011 issue of the New Jersey Register. The re-proposed rules supersede those published in November of 2010. The DHSS will hold a public hearing on the re-proposed rules on March 7, between 10 a.m. and noon, at the DHSS office in Trenton. Comments on the re-proposed rules are due on April 23. MSNJ commented on the rules proposed in November of 2010 and will evaluate whether further comments are necessary.

Proposed Rules for the Medicinal Marijuana Program [pdf 140k]

2010 © Harmony Foundation.